5th Clinical Trial Agreements Conference

August 21-22 Philadelphia and Virtual

Click here to register ($1896)

Safeguard Clinical Data and IP, Accelerate Negotiation Timelines, Explore Technological Advances, and Dissect Budgetary Restraints

Clinical trial agreements are the backbone of every relationship between sponsors, CROs, and the research
institution. Some of the biggest challenges when handling these agreements are budget negotiation,
communication transparency, language determination, and technological advancements. Are you prepared to
learn the best strategies on how to accelerate your CTA negotiations?

Join us on August 21-22nd for DGE's 5th Clinical Trial Agreements conference! Back by popular demand, our all
new agenda provides answers to your most urgent questions about remote monitoring, fair market value, GDPR
compliance, AI advancements, and much more!

All New Sessions

Agenda

Day One August 21

• 9:00 - PANEL: Enhance CommunicationTransparency Among Sponsors, CROs, and Sites
  
• 9:45 - 9:45 AM FIRESIDE CHAT: Evaluate the Impact of CROs on Negotiation Timelines
• 11:45 - 11:45 AM PANEL: Fast-Track Your CTA Negotiations: Key Factors and Best Practices
• 11:00 - Panel: Master the Art of Contract Negotiation: Real-World Strategies and Tactics
• 12:00 - Lunch and Networking
• 1:45 - FIRESIDE CHAT: Examine the Recent FDAGuidance Surrounding Digital Health Technologies
• 2:30 - Reach Consensus Between Sites and Sponsors in Budget Negotiation
• 4:30 - FIRESIDE CHAT: Identify the Correct Language for Managing Insurance

Day Two August 22

• 9:00 - Apply Key Lessons from Decentralized and Remote Clinical Trials/li>
• 9:45 - Panel: Revolutionize Contract Review Processes by Harnessing AI to Enhance Operational Efficiency
• 11:00 - FIRESIDE CHAT: Strategize How to Accelerate Negotiations for Indemnification
• 11:45 - Discover Future Trends in Clinical Trial Agreements: AI, M&A and Beyond
• 1:45 - Map out CTAs in a Global Landscape
• 2:30 - Build a Modern-Day Clinical Site Budget: Hybrid Studies, DCT, and Naive Sites
• 3:15 - PM Master GDPR Compliance in CTAs: A Step-by-Step Approach

Speakers

• Karl Dorwart, VP, Healthcare, Life Sciences and Consumer Staples Industry Lead, FACTOR
• Jessica Anderson, Director, Corporate Council, OTSUKA
• Kristy Averette, Research Practice Manager, DUKE UNIVERSITY SCHOOL OF MEDICINE
• Rachael Baker, Sr. Manager, Grants and Contracts, CELLDEX THERAPEUTICS
• John Balzano, Partner, COVINGTON & BURLING LLP
• Tina Bowdish, Senior Director, Clinical Research Administration, VANDERBILT-INGRAM CANCER CENTER
• Maureen Cawley, Senior Director, Corporate Counsel, INCYTE
• Monica Chmielewski, Partner, FOLEY & LARDNER LLP
• Jessica Taylor-Lewis, Budgets and Contracts Coordinator, ARIZONA LIVER HEALTH
• Devin Cohen, Partner, ROPES & GRAY LLP
• Kyle Faget, Partner, FOLEY & LARDNER LLP
• Andrew Gaynor, Budget and Contract Manager, GSK
• John Haeger, Manager Clinical Trial Contracts, HCA HEALTHCARE
• Adwin Hesseltine, Assistant General Council, MOFFITT CANCER CENTER
• Darshan Kulkarni, Regulatory and Compliance Attorney for the Life Sciences, THE KULKARNI LAW FIRM
• Alan Minsk, Partner, ARNALL GOLDEN GREGORY LLP
• Anika Nahar, Contracts and Budget Lead, SITEBRIDGE RESEARCH
• Jamie Peal, Attorney at Law, Independent Contractor/Outside Legal Counsel, MOFFITT CANCER CENTER
• Jacob Peterson, Budgets and Contracts Manager, ARIZONA LIVER HEALTH
• Maureen Rogalski, Associate Director, Contracts and Legal Operations, ENTRADA THERAPEUTICS
• Nancy Sacco, Head, Clinical Site Development Operations, SITEBRIDGE RESEARCH
• Stephen Smith, Head, Global R&D Legal, SANOFI
• Kathryn Tabb, Senior Director, Clinical Counsel, BRISTOL MYERS SQUIBB